IFNG and neoplasm: IFN-γ signaling can promote the binding of immunosuppressive molecules on the surface membranes of tumor cells and host myeloid cells and upregulate the expression of immunosuppressive proteins on these cells, thereby establishing an immune microenvironment conducive to tumor progression [19].